Detalhe da pesquisa
1.
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells.
Nucleic Acids Res
; 46(9): 4456-4468, 2018 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-29538770
2.
Rescue of DNA-PK Signaling and T-Cell Differentiation by Targeted Genome Editing in a prkdc Deficient iPSC Disease Model.
PLoS Genet
; 11(5): e1005239, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26000857
3.
Delivery of Designer Epigenome Modifiers into Primary Human T Cells.
Methods Mol Biol
; 1767: 189-203, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29524135
4.
Proven and novel strategies for efficient editing of the human genome.
Curr Opin Pharmacol
; 24: 105-12, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26342909
5.
Erratum to: Delivery of Designer Epigenome Modifiers into Primary Human T Cells.
Methods Mol Biol
; 1767: E1, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29748848